Advertisement
Australia markets closed
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • AUD/USD

    0.6410
    -0.0015 (-0.24%)
     
  • OIL

    82.26
    -0.47 (-0.57%)
     
  • GOLD

    2,392.70
    -5.30 (-0.22%)
     
  • Bitcoin AUD

    101,331.40
    +3,514.97 (+3.59%)
     
  • CMC Crypto 200

    1,338.87
    +26.25 (+2.04%)
     
  • AUD/EUR

    0.6015
    -0.0016 (-0.27%)
     
  • AUD/NZD

    1.0892
    +0.0017 (+0.16%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,835.26
    -41.79 (-0.53%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,722.40
    -115.00 (-0.64%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

3 Things Investors Will Love About Doximity (and 1 They Won't)

3 Things Investors Will Love About Doximity (and 1 They Won't)

Doximity (NYSE: DOCS) was viewed as an exciting, fast-growing telehealth company when it went public in 2021. Here's a look at three reasons why Doximity makes for an attractive investment, as well as a potentially important reason to hold off on adding the stock to your portfolio right now. One of the most important numbers for growth-oriented companies is the revenue retention rate, which tells you how much more (or less) customers are spending with a business compared to the previous year.